A Phase 1, Open-Label, Controlled Clinical Trial to Determine the Pulmonary Residence Time of Insulin and Fumaryl Diketopiperazine, Utilizing Bronchoalveolar Lavage, After Administration of Technosphere Insulin Inhalation Powder in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Dec 2013
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 22 May 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 22 May 2009 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 22 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.